drugset / Trial / NCT00477048
Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity
Phase 2
Completed
30 enrolled
The HIV Netherlands Australia Thailand Research Collaboration
Ministry of Health, Thailand · collabRoche Pharma AG · collab
NaSingle-groupOpen-labelTreatment
Summary
Efficacy and safety of a saquinavir (SQV) based regimen in HIV-1 infected Thai patients who have chronic indinavir (IDV) associated nephrotoxicity.
Timeline
- Start
- 2004-05
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Saquinavir | Small molecule | 1000 unknown | — |
| Subject | Saquinavir | Small molecule | 1600 unknown | — |